HCCM
MRNA icon

Hudson Canyon Capital Management’s Moderna MRNA Stock Holding History

Hudson Canyon Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,441
Closed -$904K – 55
2023
Q2 		$904K Hold
7,441
– – 0.71% 55
2023
Q1 		$1.14M Buy
7,441
+651
+10% +$107K 0.96% 56
2022
Q4 		$1.22M Hold
6,790
– – 1.13% 51
2022
Q3 		$803K Hold
6,790
– – 0.8% 54
2022
Q2 		$970K Buy
6,790
+65
+1% +$9.29K 0.94% 54
2022
Q1 		$1.16M Buy
6,725
+525
+8% +$88.4K 0.92% 56
2021
Q4 		$1.57M Buy
6,200
+2,200
+55% +$643K 1.14% 52
2021
Q3 		$1.54M Buy
+4,000
New +$1.48M 1.18% 53

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Hudson Canyon Capital Management's MRNA Position: Q3 2023 in Review

Hudson Canyon Capital Management sold out of Moderna (MRNA) in Q3 2023, closing a stake of 7,441 shares — an estimated $904K sold.

Hudson Canyon Capital Management first reported a position in MRNA in Q3 2021 and held it in 8 quarters. The position peaked at $1.57M in Q4 2021. 890 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Hudson Canyon Capital Management reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Hudson Canyon Capital Management sold 7,441 Moderna shares in Q3 2023, an estimated $904K.
  • Hudson Canyon Capital Management first reported a position in Moderna in Q3 2021 and held it in 8 quarters.
  • Hudson Canyon Capital Management's Moderna position peaked at $1.57M in Q4 2021.
  • 890 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Hudson Canyon Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.